Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1212-1221 , September 2010

Advancement of Pediatric Blood and Marrow Transplantation Research in North America: Priorities of the Pediatric Blood and Marrow Transplant Consortium

  • Michael A. Pulsipher

      Affiliations

    • Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, Utah
    • Corresponding Author InformationCorrespondence and reprint requests: Michael A. Pulsipher, MD, University of Utah School of Medicine, Division of Hematology/Blood and Marrow Transplant, 30 North 1900 East, Room 5C402, Salt Lake City, UT 84132-2408.
    • ,
  • Edwin M. Horwitz

      Affiliations

    • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • ,
  • Ann E. Haight

      Affiliations

    • Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Richard Kadota

      Affiliations

    • Rady Children's Hospital, San Diego, California
    • ,
  • Allen R. Chen

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Haydar Frangoul

      Affiliations

    • Monroe Carell Jr Children's Hospital at Vanderbilt Children's Hospital, Nashville, Tennessee
    • ,
  • Laurence J.N. Cooper

      Affiliations

    • Children's Cancer Hospital, M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • David A. Jacobsohn

      Affiliations

    • Children's Memorial Medical Center at Chicago, Chicago, Illinois
    • ,
  • Rakesh K. Goyal

      Affiliations

    • Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • David Mitchell

      Affiliations

    • Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Michael L. Nieder

      Affiliations

    • All Children's Hospital, St. Petersburg, Florida
    • ,
  • Gregory Yanik

      Affiliations

    • C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan
    • ,
  • Morton J. Cowan

      Affiliations

    • University of California San Francisco School of Medicine, San Francisco, California
    • ,
  • Sandeep Soni

      Affiliations

    • Nationwide Children'sHospital, Columbus, Ohio
    • ,
  • Sharon Gardner

      Affiliations

    • NYU Medical Center, Hassenfeld Children's Center, New York University, New York, New York
    • ,
  • Shalini Shenoy

      Affiliations

    • Washington University Medical Center, Washington University, St Louis, Missouri
    • ,
  • Douglas Taylor

      Affiliations

    • University of California Medical Center, University of California Davis, Sacramento, California
    • ,
  • Mitchell Cairo

      Affiliations

    • Columbia Presbyterian College of Physicians and Surgeons, New York, New York
    • ,
  • Kirk R. Schultz

      Affiliations

    • British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada

Received 5 November 2009 ,Accepted 30 December 2009.

References 

  1. Baker KS, Filipovich AH, Gross TG, et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2008;42:175–180
  2. Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 2008;41:109–117
  3. Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519–528
  4. Shenoy S, Grossman WJ, DiPersio J, et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant. 2005;35:345–352
  5. Griffith LM, Cowan MJ, Kohn DB, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122:1087–1096
  6. Dvorak CC, Cowan MJ. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant. 2008;41:119–126
  7. Duffner PK, Caggana M, Orsini JJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol. 2009;40:245–252
  8. Yoshimi A, Kojima S, Taniguchi S, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant. 2008;14:1057–1063
  9. Chan KW, McDonald L, Lim D, et al. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant. 2008;42:589–595
  10. Bader P, Kreyenberg H, Henze GH, et al. Prognostic value of minimal residual disease quantification before allogeneic stem cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol. 2009;27:377–384
  11. Uzunel M, Mattsson J, Jaksch M, et al. The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood. 2001;98:1982–1984
  12. Pulsipher MA, Boucher KM, Wall D, et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood. 2009;114:1429–1436
  13. Pulsipher MA, Bader P, Klingebiel T, et al. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biol Blood Marrow Transplant. 2008;15:62–71
  14. Frangoul H, Nemecek ER, Billheimer D, et al. A prospective study of G-CSF– primed bone marrow as a stem cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood. 2007;110:4584–4587
  15. Grupp SA, Verneris M, Sondel PM, et al. Immunotherapy for pediatric cancer. Biol Blood Marrow Transplant. 2008;14:33–43
  16. Cooper LJ. Adoptive cellular immunotherapy for childhood malignancies. Bone Marrow Transplant. 2008;41:183–192
  17. Jacobsohn DA. Acute graft-versus-host disease in children. Bone Marrow Transplant. 2008;41:215–221
  18. Lee SJ, Zahrieh D, Agura E, et al. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood. 2004;104:1559–1564
  19. Goyal RK, Fairfull L, Livote E, et al. TNF-α and TNF receptor superfamily member 1B polymorphisms predict risk of acute GVHD following matched unrelated donor BMT in children. Biol Blood Marrow Transplant. 2008;14:24
  20. Jacobsohn DA, Gilman AL, Rademaker A, et al. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood. 2009;114:4354–4360
  21. Aquino VM, Harvey AR, Garvin JH, et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant. 2005;36:611–616
  22. Sanders JE, Im HJ, Hoffmeister PA, et al. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood. 2005;105:3749–3756
  23. Phipps S, Dunavant M, Srivastava DK, et al. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol. 2000;18:1004–1011
  24. Phipps S, Rai SN, Leung WH, et al. Cognitive and academic consequences of stem cell transplantation in children. J Clin Oncol. 2008;26:2027–2033
  25. Eapen M, Raetz E, Zhang MJ, et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006;107:4961–4967
  26. Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant. 2004;8(Suppl 5):39–50
  27. Howard DS, Phillips IG, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29:1494–1501
  28. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32:871–876
  29. Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13:74–81
  30. Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol. 2005;130:595–603
  31. Toth K, Spencer JF, Dhar D, et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc Natl Acad Sci USA. 2008;105:7293–7297

 Financial disclosure: See Acknowledgments on page 1219.

PII: S1083-8791(10)00003-0

doi: 10.1016/j.bbmt.2009.12.536

Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1212-1221 , September 2010

Article Tools